Management Strategy of High-Risk Localized Prostate Cancer: Is there a Transatlantic Consensus?
A 70-year-old male patient with neither significant comorbidities nor symptoms was referred to our department for prostate cancer radiation therapy. The last prostate-specific antigen value was 30 ng/mL. Transrectal ultrasound guided biopsy findings confirmed the presence of prostatic adenocarcinoma without neuroendocrine component in 11 out of 12 cores, with the following distribution: in 3 of 3 cores in the right lobe, Gleason score (GS) was 7(4 + 3); in the left lobe, 5 cores corresponded to GS 7 (4 + 3), 2 cores were GS 8(4 + 4), and 1 was GS 7(3 + 4).
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Yazid Belkacemi, Gabriele Coraggio, Gokoulakrichenane Loganadane, Transatlantic Radiation Oncology Network (TRONE) Source Type: research
More News: Adenocarcinoma | Biology | Brain | Cancer | Cancer & Oncology | Neurology | Physics | Prostate Cancer | Radiation Therapy | Radiology | Ultrasound